Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
1.
BMC Med ; 7: 69, 2009 Nov 09.
Artigo em Inglês | MEDLINE | ID: mdl-19900264

RESUMO

BACKGROUND: Recently published results from a large randomized trial (Canadian Cervical Cancer Screening Trial study group) suggest that human papillomavirus testing followed by Pap smear-based triage for human papillomavirus positive women may be an effective way to screen women for cervical cancer. We determined the potential cost-effectiveness of including human papillomavirus tests for cervical cancer screening for Canada and three provinces: Alberta, Newfoundland and Ontario. METHODS: We developed four Markov decision models using data from relevant Canadian and provincial studies and databases. The models were used to determine the number of false positive test results, cancers, lifetime costs and life-expectancy for 27 different screening strategies that varied by age to begin screening (18 or 25 years), screening interval (one, two, three, or five years) and whether the currently recommended strategy (screening every year from age 18 until 21 and then every three years afterwards with conventional Paps) was conducted prior to age 25. Strategies were compared using incremental cost-effectiveness ratios. RESULTS: Screening strategies beginning at age 18 were associated with a substantial increase in the number of false-positive test results but only small differences in the number of cancers compared to the same strategy conducted beginning at age 25. Strategies of human papillomavirus testing first, followed by triage with Pap smears were associated with lower costs and greater increases in life-expectancy than the currently recommended screening strategy in Canada. CONCLUSION: A strategy of human papillomavirus testing beginning at age 25, with Pap triage for women with positive human papillomavirus results may be more effective at reducing cervical cancer at a lower cost than the current recommended strategy for screening in Canada.


Assuntos
Colo do Útero/patologia , Colo do Útero/virologia , Programas de Rastreamento/métodos , Teste de Papanicolaou , Infecções por Papillomavirus/diagnóstico , Neoplasias do Colo do Útero/economia , Neoplasias do Colo do Útero/prevenção & controle , Esfregaço Vaginal/economia , Adolescente , Adulto , Alberta , Análise Custo-Benefício , Feminino , Humanos , Terra Nova e Labrador , Ontário , Neoplasias do Colo do Útero/virologia , Adulto Jovem
3.
Cell Mol Life Sci ; 62(3): 257-70, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15723162

RESUMO

Receptors for hormones of the hypothalamic-pituitary-gonadal (HPG) axis that regulate reproductive function are expressed throughout the brain, and in particular the limbic system. The most studied of these hormones, the sex steroids, contain receptors throughout the brain, and numerous estrogenic, progestrogenic and androgenic effects have been reported in the brain related to development, maintenance and cognitive functions. Although less studied, receptors for gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH) and activins also are found throughout the limbic system on a number of cell types, and they too transduce signals from circulating hormones as demonstrated by their multiple effects on the growth, development, maintenance and function of the brain. This review highlights the point that because of the feedback loops within the HPG axis, it is difficult to ascribe structural and functional changes during development, adulthood and senescence to a single HPG hormone, since a change in the concentration of any hormone in the axis will modulate hormone concentrations and/or receptor expression patterns for all other members of the axis. The most studied of these situations is the change in serum and neuronal concentrations of HPG hormones associated with menopause/andropause. Dysregulation of the HPG axis at this time results in increases in the concentrations of serum GnRH, gonadotropins and activins, decreases in the serum concentrations of sex steroid and inhibin, and increases in GnRH and LH receptor expression. Such changes would result in significantly altered neuronal signaling, with the final result being that there is i.e. increased neuronal GnRH, LH and activin signaling, but decreased sex steroid signaling. Therefore, loss of cognitive function during senescence, typically ascribed to sex steroids, may also result from increased signaling via GnRH, LH or activin receptors. Future studies will be required to differentiate which hormones of the HPG axis regulate/maintain cognitive function. This introductory review highlights the importance of the identification of HPG hormone neuronal receptors and the potential of serum HPG hormones to transduce signals to regulate brain structure and function during development and adult life.


Assuntos
Encéfalo/fisiologia , Hormônios Gonadais/fisiologia , Sistema Hipotálamo-Hipofisário/fisiologia , Adulto , Criança , Feminino , Hormônios Gonadais/sangue , Humanos , Masculino
4.
Cell Mol Life Sci ; 62(3): 293-8, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15723165

RESUMO

Differences in the prevalence and age of onset of Alzheimer disease (AD) in men and women, and observations that hormone replacement therapy (HRT) may prevent the development of AD, caused many to hypothesize that estrogen deficiency contributes to AD. However, recent trials using estrogen failed to show any benefit in preventing or alleviating the disease. To address this and other inconsistencies in the estrogen hypothesis, we suspect that another hormone of the hypothalamic-pituitary-gonadal axis, luteinizing hormone (LH), as a major factor in AD pathogenesis. Individuals with AD have elevated levels of LH when compared with controls, and both LH and its receptor are present in increased quantities in brain regions susceptible to degeneration in AD. LH is also known to be mitogenic, and could therefore initiate the cell cycle abnormalities known to be present in AD-affected neurons. In cell culture, LH increases amyloidogenic processing of amyloid-beta protein precursor, and in animal models of AD, pharmacologic suppression of LH and FSH reduces plaque formation. Given the evidence supporting a pathogenic role for LH in AD, a trial of leuprolide acetate, which suppresses LH release, has been initiated in patients.


Assuntos
Doença de Alzheimer/etiologia , Doença de Alzheimer/fisiopatologia , Gonadotropinas/fisiologia , Envelhecimento/fisiologia , Doença de Alzheimer/prevenção & controle , Feminino , Humanos , Hormônio Luteinizante/uso terapêutico , Masculino
5.
Curr Drug Targets ; 5(6): 559-63, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15270202

RESUMO

In this review, we discuss the role of cell cycle dysfunction in the pathogenesis of Alzheimer disease and propose that such mitotic catastrophe, as one of the earliest events in neuronal degeneration, may, in fact, be sufficient to initiate the neurodegenerative cascade. The question as to what molecule initiates cell cycle dysfunction is now beginning to become understood and, in this regard, the gender-predication, age-related penetrance and regional susceptibility of specific neuronal populations led us to consider luteinizing hormone as a key mediator of the abnormal mitotic process. As such, agents targeted toward luteinizing hormone or downstream sequelae may be of great therapeutic value in the treatment of Alzheimer disease.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/etiologia , Mitose/fisiologia , Degeneração Neural/etiologia , Caracteres Sexuais , Doença de Alzheimer/patologia , Animais , Previsões , Humanos , Mitose/efeitos dos fármacos , Modelos Biológicos , Degeneração Neural/patologia , Tecnologia Farmacêutica/tendências
6.
Ann Hum Biol ; 30(6): 639-67, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14675907

RESUMO

This paper reviews a wide range of recent studies that have linked AD-associated biochemical and physiological changes with oxidative stress and damage. Some of these changes include disruptions in metal ion homeostasis, mitochondrial damage, reduced glucose metabolism, decreased intracellular pH and inflammation. Although the changes mentioned above are associated with oxidative stress, in most cases, a cause and effect relationship is not clearcut, as many changes are interlinked. Increases in the levels of Abeta peptides, the main protein components of the cerebral amyloid deposits of AD, have been demonstrated to occur in inherited early-onset forms of AD, and as a result of certain environmental and genetic risk factors. Abeta peptides have been shown to exhibit superoxide dismutase activity, producing hydrogen peroxide which may be responsible for the neurotoxicity exhibited by this peptide in vitro. This review also discusses the biochemical aspects of oxidative stress, antioxidant defence mechanisms, and possible antioxidant therapeutic measures which may be effective in counteracting increased levels of oxidative stress. In conclusion, this review provides support for the theory that damage caused by free radicals and oxidative stress is a primary cause of the neurodegeneration seen in AD with Abeta postulated as an initiator of this process.


Assuntos
Doença de Alzheimer , Peptídeos beta-Amiloides , Estilo de Vida , Estresse Oxidativo/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Adulto , Idoso , Doença de Alzheimer/etiologia , Doença de Alzheimer/genética , Doença de Alzheimer/metabolismo , Peptídeos beta-Amiloides/metabolismo , Peptídeos beta-Amiloides/fisiologia , Apolipoproteínas E/fisiologia , Dieta , Radicais Livres/efeitos adversos , Humanos , Pessoa de Meia-Idade , Fatores de Risco
7.
J Neural Transm Suppl ; (62): 69-75, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12456052

RESUMO

Over the past decade, oxidative stress has been established as the earliest cytological feature of Alzheimer disease and an attractive therapeutic target. The major challenges now are establishing the source of the reactive oxygen and what oxidative stress tells us about the etiology of Alzheimer disease. These are complex issues since a variety of enzymatic and non-enzymatic processes are involved in reactive oxygen formation and damage to macromolecules. In this review, we consider disease mechanisms that show the greatest promise for future research.


Assuntos
Doença de Alzheimer/metabolismo , Encéfalo/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Idoso , Humanos
9.
Mech Ageing Dev ; 123(1): 39-46, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11640950

RESUMO

There are multiple lines of evidence showing that oxidative stress and aberrant mitogenic signaling play an important role in the pathogenesis of Alzheimer disease. However, the chronological relationship between these and other events associated with disease pathogenesis is not known. Given the important role that mitogen-activated protein kinase (MAPK) pathways play in both mitogenic signaling (ERK) and cellular stress signaling (JNK/SAPK and p38), we investigated the chronological and spatial relationship between activated ERK, JNK/SAPK and p38 during disease progression. While all three kinases are activated in the same susceptible neurons in mild and severe cases (Braak stages III-VI), in non-demented cases with limited pathology (Braak stages I and II), both ERK and JNK/SAPK are activated but p38 is not. However, in non-demented cases lacking any sign of pathology (Braak stage 0), either ERK alone or JNK/SAPK alone can be activated. Taken together, these findings indicate that MAPK pathways are differentially activated during the course of Alzheimer disease and, by inference, suggest that both oxidative stress and abnormalities in mitotic signaling can independently serve to initiate, but both are necessary to propagate, disease pathogenesis. Therefore, we propose that both 'hits', oxidative stress and mitotic alterations, are necessary for the progression of Alzheimer disease.


Assuntos
Doença de Alzheimer/enzimologia , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neurônios/enzimologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/patologia , Córtex Cerebral/enzimologia , Córtex Cerebral/patologia , Ativação Enzimática , Hipocampo/enzimologia , Hipocampo/patologia , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno , Pessoa de Meia-Idade , Proteína Quinase 3 Ativada por Mitógeno , Fosforilação , Proteínas Quinases p38 Ativadas por Mitógeno
10.
J Neuropathol Exp Neurol ; 60(8): 759-67, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11487050

RESUMO

Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.


Assuntos
Doença de Alzheimer/metabolismo , Estresse Oxidativo , Tirosina/análogos & derivados , Idoso , Doença de Alzheimer/patologia , Doença de Alzheimer/psicologia , Peptídeos beta-Amiloides/metabolismo , Apolipoproteínas E/genética , Encéfalo/metabolismo , Encéfalo/patologia , Progressão da Doença , Feminino , Genótipo , Guanosina/análogos & derivados , Guanosina/metabolismo , Heterozigoto , Humanos , Masculino , Pessoa de Meia-Idade , Emaranhados Neurofibrilares/patologia , Neurônios/metabolismo , Neurônios/patologia , Placa Amiloide/metabolismo , Placa Amiloide/patologia , Tirosina/metabolismo
11.
Free Radic Biol Med ; 31(2): 175-80, 2001 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-11440829

RESUMO

Advanced glycation end products are a diverse class of posttranslational modifications, stemming from reactive aldehyde reactions, that have been implicated in the pathogenesis of a number of degenerative diseases. Because advanced glycation end products are accelerated by, and result in formation of, oxygen-derived free radicals, they represent an important component of the oxidative stress hypothesis of Alzheimer disease (AD). In this study, we used in situ techniques to assess N(epsilon)-(Carboxymethyl)lysine (CML), the predominant advanced glycation end product that accumulates in vivo, along with its glycation-specific precursor hexitol-lysine, in patients with AD as well as in young and aged-matched control cases. Both CML and hexitol-lysine were increased in neurons, especially those containing intracellular neurofibrillary pathology in cases of AD. The increase in hexitol-lysine and CML in AD suggests that glycation is an early event in disease pathogenesis. In addition, because CML can result from either lipid peroxidation or advanced glycation, while hexitol-lysine is solely a product of glycation, this study, together with studies demonstrating the presence of 4-hydroxy-2-nonenal adducts and pentosidine, provides evidence of two distinct oxidative processes acting in concert in AD neuropathology. Our findings support the notion that aldehyde-mediated modifications, together with oxyradical-mediated modifications, are critical pathogenic factors in AD.


Assuntos
Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Produtos Finais de Glicação Avançada/metabolismo , Lisina/análogos & derivados , Lisina/metabolismo , Emaranhados Neurofibrilares/metabolismo , Emaranhados Neurofibrilares/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/etiologia , Estudos de Casos e Controles , Radicais Livres/metabolismo , Glicosilação , Humanos , Pessoa de Meia-Idade
12.
Neuron ; 30(3): 665-76, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11430801

RESUMO

Inhibition of neocortical beta-amyloid (Abeta) accumulation may be essential in an effective therapeutic intervention for Alzheimer's disease (AD). Cu and Zn are enriched in Abeta deposits in AD, which are solubilized by Cu/Zn-selective chelators in vitro. Here we report a 49% decrease in brain Abeta deposition (-375 microg/g wet weight, p = 0.0001) in a blinded study of APP2576 transgenic mice treated orally for 9 weeks with clioquinol, an antibiotic and bioavailable Cu/Zn chelator. This was accompanied by a modest increase in soluble Abeta (1.45% of total cerebral Abeta); APP, synaptophysin, and GFAP levels were unaffected. General health and body weight parameters were significantly more stable in the treated animals. These results support targeting the interactions of Cu and Zn with Abeta as a novel therapy for the prevention and treatment of AD.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Peptídeos beta-Amiloides/metabolismo , Quelantes/farmacologia , Clioquinol/farmacologia , Cobre/metabolismo , Zinco/metabolismo , Fatores Etários , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Animais , Feminino , Proteína Glial Fibrilar Ácida/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos , Camundongos Transgênicos , Placa Amiloide/metabolismo , Placa Amiloide/patologia , Sinaptofisina/metabolismo
13.
J Neurosci ; 21(9): 3017-23, 2001 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-11312286

RESUMO

The finding that oxidative damage, including that to nucleic acids, in Alzheimer's disease is primarily limited to the cytoplasm of susceptible neuronal populations suggests that mitochondrial abnormalities might be part of the spectrum of chronic oxidative stress of Alzheimer's disease. In this study, we used in situ hybridization to mitochondrial DNA (mtDNA), immunocytochemistry of cytochrome oxidase, and morphometry of electron micrographs of biopsy specimens to determine whether there are mitochondrial abnormalities in Alzheimer's disease and their relationship to oxidative damage marked by 8-hydroxyguanosine and nitrotyrosine. We found that the same neurons showing increased oxidative damage in Alzheimer's disease have a striking and significant increase in mtDNA and cytochrome oxidase. Surprisingly, much of the mtDNA and cytochrome oxidase is found in the neuronal cytoplasm and in the case of mtDNA, the vacuoles associated with lipofuscin. Morphometric analysis showed that mitochondria are significantly reduced in Alzheimer's disease. The relationship shown here between the site and extent of mitochondrial abnormalities and oxidative damage suggests an intimate and early association between these features in Alzheimer's disease.


Assuntos
Doença de Alzheimer/patologia , Guanosina/análogos & derivados , Mitocôndrias/patologia , Mitocôndrias/ultraestrutura , Estresse Oxidativo , Tirosina/análogos & derivados , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/etiologia , Cerebelo/patologia , Cerebelo/ultraestrutura , Criança , Pré-Escolar , DNA Mitocondrial/metabolismo , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Lobo Frontal/patologia , Lobo Frontal/ultraestrutura , Guanosina/metabolismo , Hipocampo/patologia , Hipocampo/ultraestrutura , Humanos , Imuno-Histoquímica , Hibridização In Situ , Microscopia Eletrônica , Pessoa de Meia-Idade , Mitocôndrias/metabolismo , Neurônios/metabolismo , Neurônios/patologia , Neurônios/ultraestrutura , Lobo Temporal/patologia , Lobo Temporal/ultraestrutura , Tirosina/metabolismo
15.
Free Radic Biol Med ; 30(4): 447-50, 2001 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-11182300

RESUMO

While amyloid-beta toxicity is mediated by oxidative stress and can be attenuated by antioxidants, the actual biochemical mechanism underlying neurotoxicity remains to be established. However, since aggregated amyloid-beta can interact with transition metals, such as iron, both in vitro and in vivo, we suspected that bound iron might be the mediator of toxicity such that holo- and apo-amyloid would have differential effects on cellular viability. Here we demonstrate that when amyloid-beta is pretreated with the iron chelator deferoxamine, neuronal toxicity is significantly attenuated while conversely, incubation of holo-amyloid-beta with excess free iron restores toxicity to original levels. These data, taken together with the known sequelae of amyloid-beta, suggest that the toxicity of amyloid-beta is mediated, at least in part, via redox-active iron that precipitates lipid peroxidation and cellular oxidative stress.


Assuntos
Peptídeos beta-Amiloides/toxicidade , Antioxidantes/farmacologia , Ferro/fisiologia , Neurônios/efeitos dos fármacos , Morte Celular/efeitos dos fármacos , Desferroxamina/farmacologia , Humanos , Neuroblastoma , Neurônios/metabolismo , Estresse Oxidativo , Células Tumorais Cultivadas
16.
J Bacteriol ; 183(3): 921-7, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11208790

RESUMO

Deoxycytosine methylase (Dcm) enzyme activity causes mutagenesis in vitro either directly by enzyme-induced deamination of cytosine to uracil in the absence of the methyl donor, S-adenosylmethionine (SAM), or indirectly through spontaneous deamination of [5-methyl]cytosine to thymine. Using a Lac reversion assay, we investigated the contribution of the first mechanism to Dcm mutagenesis in vivo by lowering the levels of SAM. Escherichia coli SAM levels were lowered by reducing SAM synthetase activity via the introduction of a metK84 allele or by hydrolyzing SAM using the bacteriophage T3 SAM hydrolase. The metK84 strains exhibited increased C-to-T mutagenesis. Expression of the T3 SAM hydrolase gene, under the control of the arabinose-inducible P(BAD) promoter, effectively reduced Dcm-mediated genomic DNA methylation. However, increased mutagenesis was not observed until extremely high arabinose concentrations were used, and genome methylation at Dcm sites was negligible.


Assuntos
Citosina/metabolismo , DNA Glicosilases , DNA-Citosina Metilases/metabolismo , Mutagênese , Mutação Puntual , S-Adenosilmetionina/metabolismo , Timina/metabolismo , 5-Metilcitosina , Citosina/análogos & derivados , Metilação de DNA , Reparo do DNA , Escherichia coli/genética , Hidrolases/metabolismo , Modelos Genéticos , N-Glicosil Hidrolases/metabolismo , Uracila-DNA Glicosidase
17.
J Endocrinol ; 167(1): 39-52, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11018751

RESUMO

Development of the functional secretory epithelium in the mammary gland of the female mouse requires the elongation of the anlage through the mammary fat pad to form the primary/secondary ductal network from which tertiary ductal side-branches and lobuloalveoli develop. In this study we examined the hormonal requirements for the spatial development of the primary/secondary epithelial network and tertiary side-branches by quantifying ductal growth and epithelial cell proliferation in normal and hormone-treated BALB/c mice between 21 and 39 days of age. In normal mice, an allometric increase in ductal length commenced at 31 days of age and resulted in completion of the primary/secondary ductal network by 39 days of age. Concurrent with this allometric growth was a significant increase in cellular proliferation in the terminal end-buds (TEBs) of the ductal epithelium from 29 days of age, as determined by 5-bromo-2'-deoxyuridine (BrdU) incorporation. A level of cellular proliferation similar to that in the TEBs of 33-day-old control mice could be induced in the TEBs of 25-day-old mice following treatment for 1 day with estrogen (E), or progesterone (P) or both (E/P), indicating that both E and P were mitogenic for epithelial cells of the peripubertal TEBs. However, the period of allometric ductal growth in untreated mice did not correspond to an increase in serum E or P (which might have been expected during the estrous cycle). In addition, epithelial growth was not observed in mammary glands from 24-day-old mice that were cultured in vitro with E, P or E/P. In contrast to treatment with E, treatment with P promoted a dramatic increase, relative to control mice, in the number of tertiary branch points upon the primary/secondary ductal network. BrdU labeling of mammary glands from 24- 33-day-old mice pelleted with cholesterol (C), E, P or E/P confirmed the greater mitogenicity of P on the epithelial cells of the secondary/tertiary ducts as compared with C or E. Concurrent with these changes, localized progesterone receptor (PR) expression in clusters of cells in the ductal epithelium was associated with structures that histologically resembled early branch points from ductules. In conclusion, our results suggest that additional endocrine growth factor(s) other than E and P contribute to the development of the primary/secondary ductal network, and that P is responsible for the formation of tertiary side-branches in the mammary glands of mice during puberty.


Assuntos
Envelhecimento/fisiologia , Glândulas Mamárias Animais/efeitos dos fármacos , Progesterona/farmacologia , Animais , Divisão Celular , Epitélio/efeitos dos fármacos , Epitélio/crescimento & desenvolvimento , Estradiol/farmacologia , Estrogênios/sangue , Feminino , Expressão Gênica , Hibridização In Situ , Glândulas Mamárias Animais/citologia , Glândulas Mamárias Animais/crescimento & desenvolvimento , Camundongos , Camundongos Endogâmicos BALB C , Técnicas de Cultura de Órgãos , Progesterona/sangue , RNA Mensageiro/genética , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo
18.
Am J Respir Crit Care Med ; 162(2 Pt 1): 505-11, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10934078

RESUMO

Inappropriate antibiotic use for pulmonary infiltrates is common in the intensive care unit (ICU). We sought to devise an approach that would minimize unnecessary antibiotic use, recognizing that a gold standard for the diagnosis of nosocomial pneumonia does not exist. In a randomized trial, clinical pulmonary infection score (CPIS) (Pugin, J., R. Auckenthaler, N. Mili, J. P. Janssens, R. D. Lew, and P. M. Suter. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 1991;143: 1121-1129) was used as operational criteria for decision-making regarding antibiotic therapy. Patients with CPIS

Assuntos
Antibacterianos/administração & dosagem , Anti-Infecciosos/administração & dosagem , Ciprofloxacina/administração & dosagem , Infecção Hospitalar/tratamento farmacológico , Pneumonia/tratamento farmacológico , Idoso , Resistência Microbiana a Medicamentos , Humanos , Unidades de Terapia Intensiva , Tempo de Internação , Pessoa de Meia-Idade , Pneumonia/mortalidade
19.
J Neurochem ; 75(3): 1219-33, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10936205

RESUMO

Cu and Zn have been shown to accumulate in the brains of Alzheimer's disease patients. We have previously reported that Cu(2+) and Zn(2+) bind amyloid beta (Abeta), explaining their enrichment in plaque pathology. Here we detail the stoichiometries and binding affinities of multiple cooperative Cu(2+)-binding sites on synthetic Abeta1-40 and Abeta1-42. We have developed a ligand displacement technique (competitive metal capture analysis) that uses metal-chelator complexes to evaluate metal ion binding to Abeta, a notoriously self-aggregating peptide. This analysis indicated that there is a very-high-affinity Cu(2+)-binding site on Abeta1-42 (log K(app) = 17.2) that mediates peptide precipitation and that the tendency of this peptide to self-aggregate in aqueous solutions is due to the presence of trace Cu(2+) contamination (customarily approximately 0.1 microM). In contrast, Abeta1-40 has much lower affinity for Cu(2+) at this site (estimated log K(app) = 10.3), explaining why this peptide is less self-aggregating. The greater Cu(2+)-binding affinity of Abeta1-42 compared with Abeta1-40 is associated with significantly diminished negative cooperativity. The role of trace metal contamination in inducing Abeta precipitation was confirmed by the demonstration that Abeta peptide (10 microM) remained soluble for 5 days only in the presence of high-affinity Cu(2+)-selective chelators.


Assuntos
Peptídeos beta-Amiloides/química , Peptídeos beta-Amiloides/metabolismo , Cobre/metabolismo , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/metabolismo , Animais , Sítios de Ligação , Quelantes/farmacologia , Cobre/química , Cães , Humanos , Cinética , Análise de Regressão , Albumina Sérica/química , Albumina Sérica/metabolismo , Zinco/metabolismo
20.
Biochemistry ; 39(24): 7266-75, 2000 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-10852726

RESUMO

The kynurenine pathway catabolite 3-hydroxykynurenine (3HK) and redox-active metals such as copper and iron are implicated in cataractogenesis. Here we investigate the reaction of kynurenine pathway catabolites with copper and iron, as well as interactions with the major lenticular structural proteins, the alpha-crystallins. The o-aminophenol kynurenine catabolites 3HK and 3-hydroxyanthranilic acid (3HAA) reduced Cu(II)>Fe(III) to Cu(I) and Fe(II), respectively, whereas quinolinic acid and the nonphenolic kynurenine catabolites kynurenine and anthranilic acid did not reduce either metal. Both 3HK and 3HAA generated superoxide and hydrogen peroxide in a copper-dependent manner. In addition, 3HK and 3HAA fostered copper-dependent alpha-crystallin cross-linking. 3HK- or 3HAA-modifed alpha-crystallin showed enhanced redox activity in comparison to unmodified alpha-crystallin or ascorbate-modified alpha-crystallin. These data support the possibility that 3HK and 3HAA may be cofactors in the oxidative damage of proteins, such as alpha-crystallin, through interactions with redox-active metals and especially copper. These findings may have relevance for understanding cataractogenesis and other degenerative conditions in which the kynurenine pathway is activated.


Assuntos
Ácido 3-Hidroxiantranílico/metabolismo , Cristalinas/metabolismo , Peróxido de Hidrogênio/metabolismo , Cinurenina/análogos & derivados , Metais/metabolismo , Animais , Ácido Ascórbico/metabolismo , Catarata/etiologia , Bovinos , Cobre/metabolismo , Eletroquímica , Humanos , Ferro/metabolismo , Cinurenina/metabolismo , Cristalino/metabolismo , Oxirredução , Superóxidos/metabolismo , Triptofano/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA